HES1 and glioblastoma: These molecular events showed relevance in the 2OHOA mechanism of action as an antitumor drug highlighted by its main target, HES1. These findings may ultimately underlie the cell death induced by 2OHOA, suggesting that the inhibition of the Notch signaling pathway and furin proteases are relevant in the way 2OHOA acts in GBM.